Innovent Biologics Inc. earnings per share and revenue

IVBXF earnings per share for the last semiannual are -0.08 USD whereas the estimation was -0.07 USD which accounts for -14.00% surprise. Company revenue for the same period amounts to 493.68 M USD despite the estimated figure of 481.54 M USD. Estimated earnings per share for the next semiannual are -0.04 USD, and revenue is expected to reach 515.84 M USD. Also watch annual changes over time to get a bigger picture of IVBXF earnings per share and revenue dynamics.